Evidence map›Paper›PMID 30618519›Full record

ReviewPostepy dermatologii i alergologii2018

Antibiotic resistance and NG-MAST sequence types of

Beata Mlynarczyk-Bonikowska, Magdalena Malejczyk, Sławomir Majewski, Magnus Unemo

Open access · goldAbstract readReview
In one paragraph

Review in Postepy dermatologii i alergologii, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Antimicrobial susceptibilities ofCanada communicable disease report = Releve des maladies transmissibles au Canada · 2025
    Article
  3. ImprovingHeliyon · 2024
    Article
  4. Antimicrobial susceptibilities ofCanada communicable disease report = Releve des maladies transmissibles au Canada · 2023
    Article
  5. Antimicrobial susceptibilities ofCanada communicable disease report = Releve des maladies transmissibles au Canada · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Molecular epidemiological typing ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Observational
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Beata Mlynarczyk-BonikowskaDepartment of Diagnostics of Sexually Transmitted Diseases, Medical University of Warsaw, Warsaw, Poland.
Magdalena MalejczykDepartment of Diagnostics of Sexually Transmitted Diseases, Medical University of Warsaw, Warsaw, Poland.
Sławomir MajewskiDepartment of Diagnostics of Sexually Transmitted Diseases, Medical University of Warsaw, Warsaw, Poland.
Magnus UnemoWorld Health Organization (WHO) Collaborating Centre for Gonorrhoea and other STIs, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Medical University of Warsaw · PLÖrebro University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gonorrhoea is one of the most common sexually transmitted infections and in 2012, the World Health Organization estimated about 78 million of new global urogenital cases among adults per year. The main concern during the latest decade has been the emergence and spread of multidrug-resistant strains of

Indexed as

antimicrobial resistanceazithromycinceftriaxonegenogroupgonorrhoeaNeisseria gonorrhoeaeNG-MASTsequence type

Identifiers

PMID30618519
PMCPMC6320495
OpenAlexW2908379581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.